Investors in Anthropic face significant regulatory risk following a directive to all U.S. Federal Agencies to immediately cease using the company's technology and products. This directive includes a six-month phase-out period for agencies currently utilizing Anthropic services, specifically citing the Department of War. This development follows a reported $380 billion valuation round for Anthropic stock just last week.